Epalrestat

Generic Name: Epalrestat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₃NO_₃S_₂

CAS Number: 82159-09-9

Unique Ingredient Identifier: 424DV0807X

Background: Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).

Indication: 适用于糖尿病神经性病变。

Associated Conditions: -

Associated Therapies: -

Clinical Trials

The Future of Rare Disease Treatment with Precision Medicine

Rare diseases affect 7% of the world’s population, mostly genetic. Precision medicine offers tailored treatments, overcoming traditional pharmaceutical research limitations. Success stories include therapies for spinal muscle atrophy, Batten’s disease, Duchenne muscular dystrophy, and cystic fibrosis. Challenges remain in cost, ethical considerations, and data sharing, but advancements in genomic sequencing, AI, and digital technology hold promise.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy